Navigation Links
Presenting the First Ever Hands on Skills Assessment Examination for Endoscopy Certification
Date:1/25/2013

CLEVELAND, January 25, 2013 /PRNewswire/ --

Traditionally, the only way to assess technical skills in the medical field has been through unstructured, subjective observation. Therefore, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Fundamentals of Endoscopic SurgeryTM (FESTM) program has taken a giant step toward more reliable and valid measures of surgical performance to improve patient safety. As part of this initiative, SAGES together with Simbionix™, a leader in surgical simulation, have developed the first ever virtual reality system that can objectively assess surgical endoscopic skills.     

     (Logo: http://photos.prnewswire.com/prnh/20120502/529202-a)

The FES program is a comprehensive educational module and assessment tool designed to teach and test the fundamental knowledge, clinical judgment and technical skills required in the performance of basic gastrointestinal (GI) endoscopic surgery (endoscopy). FES intends to set a validated benchmark of understanding and necessary skills in basic endoscopy in order to improve the quality of patient care.

The Simbionix GI Mentor™ is a top-of-the-line endoscopic medical simulator for the training of gastrointestinal upper and lower endoscopic procedures. The simulator provides multiple training opportunities with true-to-life patient cases offering realistic scenarios of clinical situations using customized actual tools. The GI Mentor provides a comprehensive environment for practicing clinical procedures in a safe and realistic manner.

The FES test measures cognitive knowledge and judgment, and uses the GI Mentor virtual reality platform to evaluate fundamental technical skills. The educational module consists of a web-based multimedia presentation of didactic content. Those who successfully complete both the educational and assessment components will have demonstrated the basic knowledge, judgment and technical skills fundamental to the performance of endoscopic surgery.

After long development and validation of the module using the Simbionix GI Mentor, the SAGES FES exams will be officially up and running in Spring 2013. Medical professionals taking this test will be objectively assessed, with tests sites being restricted to general surgery residency programs in the US and Canada. Among the first test center sites are University Hospitals- Case Medical Center, Cleveland, Ohio; The Methodist Hospital, Houston, Texas; and McGill University Health Centre, Montreal, Quebec.

To experience the realistic virtual reality hands-on training available on the GI Mentor, visit Simbionix booth #609 at IMSH, January 27-29 in Orlando, FL.

SAGES is a not-for-profit professional membership organization which represents a worldwide community of surgeons that bring minimal access surgery, endoscopy and emerging techniques to patients in every country. Representing over 6,000 surgeons and allied health professionals, their mission is to provide leadership in surgery, particularly gastrointestinal and endoscopic surgery, in order to optimize patient care through education, research and innovation.

Simbionix USA Corporation is the world's leading provider of simulation, training and education products for medical professionals and the healthcare industry. The company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

Visit: http://www.simbionix.com   FacebookTwitter and LinkedIn.

Simbionix Contact: Rebecca Levy , Manager of Marketing Communications, at rebecca@simbionix.com, +1-216-2292040

FES Contact: Jessica Mischna , Manager of Fundamentals of Endoscopic Surgery, at Jessica@fesprogram.org



'/>"/>
SOURCE Simbionix Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Gomez Law Firm Launches New Website Representing Victims Of Defective Stryker Hip Replacement Systems
2. Synteract Sponsoring and Presenting at Outsourcing in Clinical Trials Southeast Conference
3. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
4. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
5. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
6. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
7. The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
8. Apollo Hospitals to Establish the First Proton Therapy Center for Cancer Treatment to Serve Over 3.5 Billion People
9. SafeCode Drug Technologies Corp Signs an Agreement With INTOVISION PRODUCT DEVELOPMENT & DESIGN (An Israeli Product Development Co) to Manufacturers the Worlds First Voice Recognition Drug Safety Application Prototype
10. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
11. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... OCEAN VIEW, Delaware , February 27, 2017 ... (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode ... Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., ... , Poland , Russia , ... Japan , South Korea , Taiwan ...
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working as ... Now, she writes about God, when she isn’t swimming as a performing mermaid. , Her ... BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):